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Abstract 
Magnetic particle spectroscopy (MPS) is a technology that derives from magnetic particle imaging 
(MPI) and thrives as a standalone platform for many biological and biomedical applications, 
benefiting from the facile preparation and chemical modification of magnetic nanoparticles 
(MNPs). In recent years, MPS has been reported in extensive literatures as a versatile platform for 
different bioassay purposes using artificially designed MNPs, where the MNPs serve as magnetic 
tracers, the surface functionalized reagents (e.g., antibodies, aptamers, peptides, etc.) and tiny 
probes capturing target analytes from biofluid samples. The biochemical complexes on MNP 
surfaces can be tailored for different bioassay requirements, while the design of MNPs are of less 
attention for MPS-based bioassays. For MNPs in most bioassay applications, superparamagnetism 
is prerequisite to avoid agglomerates and false magnetic signals. Single- and multi-core 
superparamagnetic nanoparticles (SPMNPs) are prevalently used in MPS-based bioassays. In this 
mini review, we compared the pros & cons of different MPS platforms realizing volumetric- and 
surface-based bioassays with single- and multi-core nanoparticles, respectively. 
Keywords: Magnetic particle spectroscopy, magnetic nanoparticle, bioassay, single-core, multi-
core 
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1. Introduction 
The application of magnetic nanoparticles (MNPs) in biological and biomedical context is a fast-
growing area. Where MNPs, with proper surface functionalization, are used as contrast agents in 
magnetic resonance imaging (MRI) and nuclear magnetic resonance (NMR)-based biosensors1–6, 
tracers for magnetic particle imaging (MPI) and magnetic particle spectroscopy (MPS)-based 
biosensors7–13, tags for magnetoresistive (MR)-based biosensors14–19, labels for cell sorting and 
separation20,21, heating sources for hyperthermia22–24, carriers for drug/gene delivery22,23, and 
surface-enhanced Raman spectroscopy (SERS)-active substrate for different biochemical assays25–
27. Iron oxide nanoparticles (IONs, e.g., Fe3O4 and γ-Fe2O3) are frequently used for these 
applications due to high biocompatibility, stability, and biodegradability. Furthermore, the quest 
for high moment MNPs using other magnetic materials such as pure metals (e.g., Fe, Co, Ni), 
alloys (e.g., FeCo, alnico, permalloy), and oxides (e.g., MFe2O4 where M = Fe, Co, Mn, Ni, Zn)
28–
30 is growing in view of higher magnetic signal and magnetic force for those aforementioned 
applications.  
Besides choosing different MNP materials with high saturation magnetizations, an alternative 
to achieve high moment MNPs is to use larger magnetic cores. With increasing magnetic core size, 
these MNPs show ferrimagnetic behavior and hysteresis loops (non-zero remanent magnetization), 
which, is preferred for some applications such as magnetic hyperthermia. However, this remanent 
magnetization leads to agglomeration of MNPs, blocking blood vessels and causing false magnetic 
signals for imaging and biosensing31–33. Thus, MNPs with superparamagnetic behaviors (zero 
remanent magnetization) are chosen for those applications. Superparamagnetism appears in very 
small MNPs when the magnetizations randomly flip due to thermal fluctuations. The core sizes of 
superparamagnetic nanoparticles (SPMNPs) are usually below several nanometers to several tens 
of nanometers depending on the materials34. Consequently, the requirement on magnetic core size 
for superparamagnetism limits the achieving of high magnetic moment SPMNPs. Thus, multi-core 
SPMNPs are designed where a cluster of smaller SPMNPs are embedded in a polymer matrix35–37. 
These relatively large, multi-core SPMNPs show negligible remanent magnetization (compared to 
single-core MNPs with the same overall size), higher colloidal stability, and low tendency to form 
agglomerates, which is an excellent alternative to single-core SPMNPs. Multi-core SPMNPs have 
also been exploited for magnetic separation38,39, MPI36,40,41, MRI42–44, and hyperthermia45. While 
for most biological and biomedical applications, single- and multi-core SPMNPs hold equally 
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important roles46–48. However, in the area of MPS-based bioassays, single-core SPMNPs are 
prevalently used and reported in most of the research articles10,12,49–54. Herein, we comment on the 
mechanism of MPS-based bioassays, the motivation of choosing single-core SPMNPs as tracers 
for traditional MPS-based bioassays. In addition, we summarize the specific scenarios where 
single- and/or multi-core SPMNPs are used. 
 
2. Mechanism of MPS-based Bioassays 
Upon the application of sinusoidal magnetic fields, the magnetic moments of SPMNPs in aqueous 
medium try to align with the fields through the joint effects of Brownian and Néel relaxation 
processes, to minimize magnetostatics energy, which are countered by the thermal fluctuations 
(kBT, where kB is the Boltzmann constant and T is temperature). Néel process is the relaxation of 
magnetic moment inside a stational SPMNP to align with external magnetic field and there is no 
physical movement related to this process. While, Brownian process is the rotational movement 
of the whole SPMNP along with its magnetic moment in response to external magnetic field. In 
addition to thermal energy that randomizes magnetic moments, Brownian process is also affected 
by the hydrodynamic volume, Vh, of SPMNP as well as the viscosity, η, of the aqueous medium. 
On the other hand, Néel process is also affected by the effective anisotropy (including crystal and 
shape anisotropies), Keff, and volume of magnetic core, Vc. These two processes jointly govern the 
ability of magnetic moments to follow the time-changing magnetic field, thus, tuning the dynamic 
magnetic responses to the field. The effective relaxation time is dominated by the faster relaxation 
process while for single-core SPMNP with magnetic core size above 25 nm (some papers and 
books reported this number to between 12 nm and 20 nm), the Brownian process will dominate 
dynamic magnetic responses of SPMNPs55–59. 
From a macro perspective, nonlinear dynamic magnetic responses of SPMNPs to external 
sinusoidal magnetic fields induce higher odd harmonics, which, are recorded by a pair of specially 
designed pick-up coils and converted into spectral components10,53,54. These higher harmonics are 
used as metrics for measuring the temperature (T) and viscosity (η) of SPMNP medium55,60–64, as 
well as the saturation magnetization (Ms), magnetic core size (Vc), and hydrodynamic size (Vh) of 
SPMNP49,65. Since the Brownian process can be altered by the hydrodynamic size of SPMNPs, 
researchers have been exploiting the Brownian process-dominated SPMNPs for MPS-based 
bioassays. MPS-based bioassays detect target analytes (chemicals/biological compounds) from 
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aqueous medium where the odd harmonics of SPMNPs are used as metrics for monitoring their 
hydrodynamic size (Vh), which, reflects the bound states of target analytes to SPMNPs
10. Where 
the capture antibodies (or aptamers, peptides, etc.) are functionalized on SPMNP surface. Target 
analytes will bind to SPMNPs through specific antibody-antigen interactions (or DNA-DNA 
interaction, RNA-RNA interaction, etc.). This specific binding process allows us to quantify target 
analytes from the aqueous testing sample. The dynamic magnetic responses of SPMNPs will be 
impaired by the conjugation of target analytes and the Brownian process is countered. As a result, 
the observed harmonics become weaker and phase lag between magnetic moments to external field 
becomes larger10,12,51,52. The magnetic signals are recorded by the pick-up coils in the format of 
time-varying voltage signals, converting the quantity of target analytes to spectral components - 
harmonics. Nowadays, MPS has been actively explored as a portable, highly sensitive, low cost, 
and easy-to-use in vitro bioassay platform. 
 
3. Single- and Multi-core SPMNPs as Tags for MPS-based Bioassays 
In the foregoing section, we mentioned the two relaxation processes that govern the dynamic 
magnetic responses of SPMNPs and explained the reasons behind choosing Brownian process-
dominated SPMNPs for MPS-based bioassays. For single-core SPMNPs suspended in aqueous 
medium, Brownian process-dominated SPMNPs could be artificially controlled and selected by 
tuning the size of particles. However, in multi-core SPMNPs, a cluster of smaller SPMNPs are 
embedded in the matrix where their Brownian process is blocked. The collective dynamic 
magnetic responses of multi-core SPMNPs and smaller SPMNPs embedded are governed by 
complicated Brownian and Néel processes. Currently, there is no theoretical models available for 
this kind of magnetic response yet. Although multi-core SPMNPs show many merits such as 
negligible remanent magnetizations and high magnetic moment per particle, the free rotational 
Brownian process of SPMNPs embedded in matrix are blocked. As a result, these multi-core 
SPMNPs are not applicable for MSP-based bioassays that utilizes the freedom of rotational motion 
(Brownian process) as metric of bound state. 
    Multi-core SPMNPs are limited by the fact that Brownian process is blocked, and this type of 
particles are rarely reported in MPS-based bioassays. However, the properties such as higher 
magnetic moment per particle and being superparamagnetic are so appealing that they are used in 
an altered form MPS-based bioassays66–69. For traditional MPS-based bioassays, single-core 
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SPMNPs are pre-functionalized with capture antibodies (or aptamers, peptides, etc.), then biofluid 
sample is added, the real-time specific binding is monitored by MPS platform from the whole 
SPMNP system, see Figure 1(A). This homogenous, volumetric-based, one-step, wash-free 
sensing scheme allows for “press one button and get the result within a few minutes”. The 
quantity/concentration of target analytes is evaluated by the change of magnetic responses 
(harmonics from MPS spectra) before and after the addition of biofluid sample. 
 
Figure 1. (A) Traditional MPS-based bioassay using single-core SPMNPs. Changes in odd 
harmonics from MPS spectra before and after adding samples as used as metrics. (B) An altered 
form MPS-based bioassay using multi-core SPMNPs. Harmonics from the captured of SPMNPs 
in the presence of target analytes are used as metrics. 
 
On the other hand, multi-core SPMNPs have been reported as tracers in altered form MPS-based 
bioassays69–72. Although the complicated joint Brownian and Néel processes of multi-core 
SPMNPs are under investigation, the nonlinear dynamic magnetic responses can be used as metrics 
to indicate the capture of multi-core SPMNPs in the presence of target analytes. In an altered form 
MPS system, a nonmagnetic substrate functionalized with capture antibodies (or aptamers, 
peptides, etc.) provides a reaction surface and it allows the specific binding of target analytes from 
biofluid sample, see Figure 1(B). Then the unbound biochemical compounds are removed by a 
flush wash step. Followed by passing detection antibody (or aptamer, etc.) functionalized multi-
core SPMNPs though the surface. These multi-core SPMNPs bound to the immunocomplex on the 
reaction surface serve as magnetic labels to be recorded by the MPS system. An extra wash step 
to flush away unbound multi-core SPMNPs prior to MPS measurement is highly suggested to 
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minimize detection error. Herein, the rotational freedom of SPMNPs is not used as metrics to 
reflect the bound states of target analytes. Instead, the nonlinear magnetic responses (due to 
superparamagnetism) of multi-core SPMNPs are recorded by MPS as metrics to quantify target 
analytes.  
 
4. Conclusive Remarks 
In summary, two types of MPS platforms, volumetric and surface-based, are reviewed. The 
volumetric-based MPS bioassay uses single-core SPMNPs and the detection of target analytes 
relies on the Brownian process of SPMNPs. While for multi-core SPMNPs where the Brownian 
process is blocked, they are used in surface-based MPS bioassay where the detection of target 
analytes relies on the dynamic magnetic responses of SPMNPs. Volumetric-based MPS bioassay 
utilizes the rotational freedom of single-core SPMNPs as metrics and the magnetic responses 
directly reflect the binding of target analytes from aqueous medium. Realizing “press one button 
and get the result within a few minutes”. This detection mechanism allows for non-technicians 
with minimum training requirements to carry out self-testing in rural areas or at home.  
    On the other hand, multi-core SPMNPs can provide higher magnetic signal per particle over the 
single-core counterparts, thus, allows for better sensitivity bioassays. Although mutli-core 
sacrificed the rotational freedom of SPMNPs, surface-based MPS bioassay scheme utilizes the 
dynamic magnetic responses of multi-core SPMNPs. By adding a reaction surface and capturing 
these multi-core SPMNPs through specific antibody-antigen interactions (or DNA-DNA 
interaction, RNA-RNA interaction, etc.), the quantity of remaining multi-core SPMNPs after 
multiple wash steps are proportional to the number of target analytes from biofluid sample. 
Surface-based MPS with multi-core SPMNPs as tracers allow for highly sensitive detection while 
requires multiple wash steps. This limits its applications in lab contexts. The pros & cons of each 
platform are summarized and compared in Table 1. 
 
Table 1. Comparison between single- and multi-core SPMNPs for MPS-based bioassays. 
Single-
core1 
Pros 
· Allows one-step wash-free 
detection. 
 · Requires multiple wash steps to 
remove unbound biochemical 
compounds and SPMNPs. 
Cons 
Multi-
core2 
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· Low cost per test: the cost mainly 
come from SPMNP and capture 
antibodies (or aptamers, peptides, 
etc.). 
 · High cost per test: extra cost 
comes from nonmagnetic substrate 
and detection antibody (or aptamer, 
etc.). 
     
Cons 
· Low magnetic signal per particle.  · High magnetic signal per particle. 
Pros 
· Low sensitivity: homogenous, 
volumetric-based bioassay, 
magnetic signal comes from whole 
SPMNP sample.  
 · High sensitivity: surface-based 
bioassay, magnetic signal only 
comes from those bound SPMNPs.  
1Single-core SPMNPs for volumetric-based MPS bioassay. 
2Multi-core SPMNPs for surface-based MPS bioassay. 
 
Associated Content 
ORCID 
Kai Wu: 0000-0002-9444-6112 
Jinming Liu: 0000-0002-4313-5816 
Diqing Su: 0000-0002-5790-8744 
Renata Saha: 0000-0002-0389-0083 
Jian-Ping Wang: 0000-0003-2815-6624 
Notes 
The authors declare no conflict of interest. 
Acknowledgments 
This study was financially supported by the Distinguished McKnight University Professorship, the 
Centennial Chair Professorship, and the Robert F Hartmann Endowed Chair from the University 
of Minnesota. 
 
References 
(1)  Huber, S.; Min, C.; Staat, C.; Oh, J.; Castro, C. M.; Haase, A.; Weissleder, R.; Gleich, B.; 
Lee, H. Multichannel Digital Heteronuclear Magnetic Resonance Biosensor. Biosens. 
Bioelectron. 2019, 126, 240–248. 
 8 
(2)  Hash, S.; Martinez-Viedma, M. P.; Fung, F.; Han, J. E.; Yang, P.; Wong, C.; Doraisamy, L.; 
Menon, S.; Lightner, D. Nuclear Magnetic Resonance Biosensor for Rapid Detection of 
Vibrio Parahaemolyticus. Biomed. J. 2019, 42 (3), 187–192. 
(3)  Zou, D.; Jin, L.; Wu, B.; Hu, L.; Chen, X.; Huang, G.; Zhang, J. Rapid Detection of 
Salmonella in Milk by Biofunctionalised Magnetic Nanoparticle Cluster Sensor Based on 
Nuclear Magnetic Resonance. Int. Dairy J. 2019, 91, 82–88. 
(4)  Jin, L.; Li, T.; Wu, B.; Yang, T.; Zou, D.; Liang, X.; Hu, L.; Huang, G.; Zhang, J. Rapid 
Detection of Salmonella in Milk by Nuclear Magnetic Resonance Based on Membrane 
Filtration Superparamagnetic Nanobiosensor. Food Control 2020, 110, 107011. 
(5)  Lin, J.; Xin, P.; An, L.; Xu, Y.; Tao, C.; Tian, Q.; Zhou, Z.; Hu, B.; Yang, S. Fe 3 O 4–ZIF-
8 Assemblies as PH and Glutathione Responsive T 2–T 1 Switching Magnetic Resonance 
Imaging Contrast Agent for Sensitive Tumor Imaging in Vivo. Chem. Commun. 2019, 55 (4), 
478–481. 
(6)  Xie, W.; Guo, Z.; Cao, Z.; Gao, Q.; Wang, D.; Boyer, C.; Kavallaris, M.; Sun, X.; Wang, X.; 
Zhao, L. Manganese-Based Magnetic Layered Double Hydroxide Nanoparticle: A PH-
Sensitive and Concurrently Enhanced T 1/T 2-Weighted Dual-Mode Magnetic Resonance 
Imaging Contrast Agent. ACS Biomater. Sci. Eng. 2019, 5 (5), 2555–2562. 
(7)  Tay, Z. W.; Hensley, D.; Ma, J.; Chandrasekharan, P.; Zheng, B.; Goodwill, P.; Conolly, S. 
Pulsed Excitation in Magnetic Particle Imaging. IEEE Trans. Med. Imaging 2019, 38 (10), 
2389–2399. 
(8)  Wu, L. C.; Zhang, Y.; Steinberg, G.; Qu, H.; Huang, S.; Cheng, M.; Bliss, T.; Du, F.; Rao, J.; 
Song, G. A Review of Magnetic Particle Imaging and Perspectives on Neuroimaging. Am. J. 
Neuroradiol. 2019, 40 (2), 206–212. 
(9)  Gräser, M.; Thieben, F.; Szwargulski, P.; Werner, F.; Gdaniec, N.; Boberg, M.; Griese, F.; 
Möddel, M.; Ludewig, P.; van de Ven, D. Human-Sized Magnetic Particle Imaging for Brain 
Applications. Nat. Commun. 2019, 10 (1), 1–9. 
(10)  Wu, K.; Su, D.; Saha, R.; Wong, D.; Wang, J.-P. Magnetic Particle Spectroscopy-Based 
Bioassays: Methods, Applications, Advances, and Future Opportunities. J. Phys. Appl. Phys. 
2019, 52, 173001. 
 9 
(11)  Viereck, T.; Draack, S.; Schilling, M.; Ludwig, F. Multi-Spectral Magnetic Particle 
Spectroscopy for the Investigation of Particle Mixtures. J. Magn. Magn. Mater. 2019, 475, 
647–651. 
(12)  Wu, K.; Liu, J.; Su, D.; Saha, R.; Wang, J.-P. Magnetic Nanoparticle Relaxation Dynamics-
Based Magnetic Particle Spectroscopy for Rapid and Wash-Free Molecular Sensing. ACS 
Appl. Mater. Interfaces 2019, 11 (26), 22979–22986. 
https://doi.org/10.1021/acsami.9b05233. 
(13)  Wu, K.; Liu, J.; Saha, R.; Su, D.; Krishna, V. D.; Cheeran, M. C.; Wang, J.-P. Magnetic 
Particle Spectroscopy (MPS) for Detection of Influenza A Virus Subtype H1N1. ACS Appl. 
Mater. Interfaces 2020. 
(14)  Ravi, N.; Rizzi, G.; Chang, S. E.; Cheung, P.; Utz, P. J.; Wang, S. X. Quantification of CDNA 
on GMR Biosensor Array towards Point-of-Care Gene Expression Analysis. Biosens. 
Bioelectron. 2019, 130, 338–343. 
(15)  Klein, T.; Wang, W.; Yu, L.; Wu, K.; Boylan, K. L.; Vogel, R. I.; Skubitz, A. P.; Wang, J.-
P. Development of a Multiplexed Giant Magnetoresistive Biosensor Array Prototype to 
Quantify Ovarian Cancer Biomarkers. Biosens. Bioelectron. 2019, 126, 301–307. 
(16)  Wu, K.; Klein, T.; Krishna, V. D.; Su, D.; Perez, A. M.; Wang, J.-P. Portable GMR Handheld 
Platform for the Detection of Influenza A Virus. ACS Sens. 2017, 2, 1594–1601. 
(17)  Gao, Y.; Huo, W.; Zhang, L.; Lian, J.; Tao, W.; Song, C.; Tang, J.; Shi, S.; Gao, Y. Multiplex 
Measurement of Twelve Tumor Markers Using a GMR Multi-Biomarker Immunoassay 
Biosensor. Biosens. Bioelectron. 2019, 123, 204–210. 
(18)  Su, D.; Wu, K.; Krishna, V.; Klein, T.; Liu, J.; Feng, Y.; Perez, A. M.; Cheeran, M. C.; Wang, 
J.-P. Detection of Influenza a Virus in Swine Nasal Swab Samples With a Wash-Free 
Magnetic Bioassay and a Handheld Giant Magnetoresistance Sensing System. Front. 
Microbiol. 2019, 10, 1077. 
(19)  Krishna, V. D.; Wu, K.; Perez, A. M.; Wang, J. P. Giant Magnetoresistance-Based Biosensor 
for Detection of Influenza A Virus. Front. Microbiol. 2016, 7, 8. 
(20)  Holt, L. M.; Olsen, M. L. Novel Applications of Magnetic Cell Sorting to Analyze Cell-Type 
Specific Gene and Protein Expression in the Central Nervous System. PLoS One 2016, 11 
(2). 
 10 
(21)  Jia, Z.; Liang, Y.; Xu, X.; Li, X.; Liu, Q.; Ou, Y.; Duan, L.; Zhu, W.; Lu, W.; Xiong, J. 
Isolation and Characterization of Human Mesenchymal Stem Cells Derived from Synovial 
Fluid by Magnetic‐activated Cell Sorting (MACS). Cell Biol. Int. 2018, 42 (3), 262–271. 
(22)  Moros, M.; Idiago-López, J.; Asín, L.; Moreno-Antolín, E.; Beola, L.; Grazú, V.; Fratila, R. 
M.; Gutiérrez, L.; de la Fuente, J. M. Triggering Antitumoural Drug Release and Gene 
Expression by Magnetic Hyperthermia. Adv. Drug Deliv. Rev. 2019, 138, 326–343. 
(23)  Zahn, D.; Weidner, A.; Saatchi, K.; Häfeli, U. O.; Dutz, S. Biodegradable Magnetic 
Microspheres for Drug Targeting, Temperature Controlled Drug Release, and Hyperthermia. 
Curr. Dir. Biomed. Eng. 2019, 5 (1), 161–164. 
(24)  Vilas-Boas, V.; Espiña, B.; Kolen’ko, Y. V.; Bañobre-López, M.; Brito, M.; Martins, V.; 
Duarte, J. A.; Petrovykh, D. Y.; Freitas, P.; Carvalho, F. Effectiveness and Safety of a 
Nontargeted Boost for a CXCR4-Targeted Magnetic Hyperthermia Treatment of Cancer 
Cells. ACS Omega 2019, 4 (1), 1931–1940. 
(25)  Zhou, Y.; Li, J.; Zhang, L.; Ge, Z.; Wang, X.; Hu, X.; Xu, T.; Li, P.; Xu, W. HS-β-
Cyclodextrin-Functionalized Ag@ Fe 3 O 4@ Ag Nanoparticles as a Surface-Enhanced 
Raman Spectroscopy Substrate for the Sensitive Detection of Butyl Benzyl Phthalate. Anal. 
Bioanal. Chem. 2019, 411 (22), 5691–5701. 
(26)  Song, D.; Yang, R.; Long, F.; Zhu, A. Applications of Magnetic Nanoparticles in Surface-
Enhanced Raman Scattering (SERS) Detection of Environmental Pollutants. J. Environ. Sci. 
2019, 80, 14–34. 
(27)  Alula, M. T.; Lemmens, P.; Bo, L.; Wulferding, D.; Yang, J.; Spende, H. Preparation of Silver 
Nanoparticles Coated ZnO/Fe3O4 Composites Using Chemical Reduction Method for 
Sensitive Detection of Uric Acid via Surface-Enhanced Raman Spectroscopy. Anal. Chim. 
Acta 2019, 1073, 62–71. 
(28)  Sun, S.; Zeng, H.; Robinson, D. B.; Raoux, S.; Rice, P. M.; Wang, S. X.; Li, G. Monodisperse 
Mfe2o4 (M= Fe, Co, Mn) Nanoparticles. J. Am. Chem. Soc. 2004, 126 (1), 273–279. 
(29)  Liu, J.; Su, D.; Wu, K.; Wang, J.-P. High-Moment Magnetic Nanoparticles. J. Nanoparticle 
Res. 2020, 22 (3), 1–16. 
(30)  Wu, K.; Su, D.; Liu, J.; Saha, R.; Wang, J.-P. Magnetic Nanoparticles in Nanomedicine: A 
Review of Recent Advances. Nanotechnology 2019, 30 (50), 502003. 
 11 
(31)  Drašler, B.; Drobne, D.; Novak, S.; Valant, J.; Boljte, S.; Otrin, L.; Rappolt, M.; Sartori, B.; 
Iglič, A.; Kralj-Iglič, V. Effects of Magnetic Cobalt Ferrite Nanoparticles on Biological and 
Artificial Lipid Membranes. Int. J. Nanomedicine 2014, 9, 1559. 
(32)  Rümenapp, C.; Gleich, B.; Haase, A. Magnetic Nanoparticles in Magnetic Resonance 
Imaging and Diagnostics. Pharm. Res. 2012, 29 (5), 1165–1179. 
(33)  Taylor, A.; Wilson, K. M.; Murray, P.; Fernig, D. G.; Lévy, R. Long-Term Tracking of Cells 
Using Inorganic Nanoparticles as Contrast Agents: Are We There Yet? Chem. Soc. Rev. 2012, 
41 (7), 2707–2717. 
(34)  Singamaneni, S.; Bliznyuk, V. N.; Binek, C.; Tsymbal, E. Y. Magnetic Nanoparticles: Recent 
Advances in Synthesis, Self-Assembly and Applications. J. Mater. Chem. 2011, 21 (42), 
16819–16845. 
(35)  Marin-Barba, M.; Gavilán, H.; Gutierrez, L.; Lozano-Velasco, E.; Rodríguez-Ramiro, I.; 
Wheeler, G. N.; Morris, C. J.; Morales, M. P.; Ruiz, A. Unravelling the Mechanisms That 
Determine the Uptake and Metabolism of Magnetic Single and Multicore Nanoparticles in a 
Xenopus Laevis Model. Nanoscale 2018, 10 (2), 690–704. 
(36)  Kratz, H.; Taupitz, M.; de Schellenberger, A. A.; Kosch, O.; Eberbeck, D.; Wagner, S.; 
Trahms, L.; Hamm, B.; Schnorr, J. Novel Magnetic Multicore Nanoparticles Designed for 
MPI and Other Biomedical Applications: From Synthesis to First in Vivo Studies. PloS One 
2018, 13 (1), e0190214. 
(37)  Bender, P.; Bogart, L. K.; Posth, O.; Szczerba, W.; Rogers, S. E.; Castro, A.; Nilsson, L.; 
Zeng, L. J.; Sugunan, A.; Sommertune, J. Structural and Magnetic Properties of Multi-Core 
Nanoparticles Analysed Using a Generalised Numerical Inversion Method. Sci. Rep. 2017, 7, 
45990. 
(38)  Jeong, A.; Lim, H. B. Magnetophoretic Separation ICP-MS Immunoassay Using Cs-Doped 
Multicore Magnetic Nanoparticles for the Determination of Salmonella Typhimurium. 
Talanta 2018, 178, 916–921. 
(39)  Witte, K.; Müller, K.; Grüttner, C.; Westphal, F.; Johansson, C. Particle Size-and 
Concentration-Dependent Separation of Magnetic Nanoparticles. J. Magn. Magn. Mater. 
2017, 427, 320–324. 
 12 
(40)  Eberbeck, D.; Dennis, C. L.; Huls, N. F.; Krycka, K. L.; Gruttner, C.; Westphal, F. Multicore 
Magnetic Nanoparticles for Magnetic Particle Imaging. IEEE Trans. Magn. 2012, 49 (1), 
269–274. 
(41)  Ota, S.; Takeda, R.; Yamada, T.; Kato, I.; Nohara, S.; Takemura, Y. Effect of Particle Size 
and Structure on Harmonic Intensity of Blood-Pooling Multi-Core Magnetic Nanoparticles 
for Magnetic Particle Imaging. Int J Magn Part. Imag 2017, 3, 1703003. 
(42)  Lartigue, L.; Hugounenq, P.; Alloyeau, D.; Clarke, S. P.; Lévy, M.; Bacri, J.-C.; Bazzi, R.; 
Brougham, D. F.; Wilhelm, C.; Gazeau, F. Cooperative Organization in Iron Oxide Multi-
Core Nanoparticles Potentiates Their Efficiency as Heating Mediators and MRI Contrast 
Agents. ACS Nano 2012, 6 (12), 10935–10949. 
(43)  Vargas-Osorio, Z.; Argibay, B.; Piñeiro, Y.; Vázquez-Vázquez, C.; López-Quintela, M. A.; 
Alvarez-Perez, M. A.; Sobrino, T.; Campos, F.; Castillo, J.; Rivas, J. Multicore Magnetic Fe 
3 O 4@ C Beads with Enhanced Magnetic Response for MRI in Brain Biomedical 
Applications. IEEE Trans. Magn. 2016, 52 (7), 1–4. 
(44)  Kostevšek, N.; Šturm, S.; Serša, I.; Sepe, A.; Bloemen, M.; Verbiest, T.; Kobe, S.; Rožman, 
K. Ž. “Single-” and “Multi-Core” FePt Nanoparticles: From Controlled Synthesis via 
Zwitterionic and Silica Bio-Functionalization to MRI Applications. J. Nanoparticle Res. 
2015, 17 (12), 464. 
(45)  Blanco-Andujar, C.; Ortega, D.; Southern, P.; Pankhurst, Q. A.; Thanh, N. T. K. High 
Performance Multi-Core Iron Oxide Nanoparticles for Magnetic Hyperthermia: Microwave 
Synthesis, and the Role of Core-to-Core Interactions. Nanoscale 2015, 7 (5), 1768–1775. 
(46)  Dutz, S.; Clement, J. H.; Eberbeck, D.; Gelbrich, T.; Hergt, R.; Müller, R.; Wotschadlo, J.; 
Zeisberger, M. Ferrofluids of Magnetic Multicore Nanoparticles for Biomedical Applications. 
J. Magn. Magn. Mater. 2009, 321 (10), 1501–1504. 
(47)  Green, L. A.; Thuy, T. T.; Mott, D. M.; Maenosono, S.; Thanh, N. T. K. Multicore Magnetic 
FePt Nanoparticles: Controlled Formation and Properties. RSC Adv. 2014, 4 (3), 1039–1044. 
(48)  Dutz, S. Are Magnetic Multicore Nanoparticles Promising Candidates for Biomedical 
Applications? IEEE Trans. Magn. 2016, 52 (9), 1–3. 
(49)  Draack, S.; Lucht, N.; Remmer, H.; Martens, M.; Fischer, B.; Schilling, M.; Ludwig, F.; 
Viereck, T. Multiparametric Magnetic Particle Spectroscopy of CoFe2O4 Nanoparticles in 
Viscous Media. J. Phys. Chem. C 2019, 123 (11), 6787–6801. 
 13 
(50)  Khurshid, H.; Shi, Y.; Berwin, B. L.; Weaver, J. B. Evaluating Blood Clot Progression Using 
Magnetic Particle Spectroscopy. Med. Phys. 2018, 45 (7), 3258–3263. 
(51)  Poller, W. C.; Löwa, N.; Wiekhorst, F.; Taupitz, M.; Wagner, S.; Möller, K.; Baumann, G.; 
Stangl, V.; Trahms, L.; Ludwig, A. Magnetic Particle Spectroscopy Reveals Dynamic 
Changes in the Magnetic Behavior of Very Small Superparamagnetic Iron Oxide 
Nanoparticles during Cellular Uptake and Enables Determination of Cell-Labeling Efficacy. 
J. Biomed. Nanotechnol. 2016, 12 (2), 337–346. 
(52)  Zhang, X.; Reeves, D. B.; Perreard, I. M.; Kett, W. C.; Griswold, K. E.; Gimi, B.; Weaver, J. 
B. Molecular Sensing with Magnetic Nanoparticles Using Magnetic Spectroscopy of 
Nanoparticle Brownian Motion. Biosens. Bioelectron. 2013, 50, 441–446. 
(53) Krause, H.-J.; Wolters, N.; Zhang, Y.; Offenhäusser, A.; Miethe, P.; Meyer, M. H.; Hartmann, 
M.; Keusgen, M. Magnetic Particle Detection by Frequency Mixing for Immunoassay 
Applications. J. Magn. Magn. Mater. 2007, 311, 436–444. 
(54)  Nikitin, P. I.; Vetoshko, P. M.; Ksenevich, T. I. New Type of Biosensor Based on Magnetic 
Nanoparticle Detection. J. Magn. Magn. Mater. 2007, 311, 445–449. 
(55)  Wu, K.; Liu, J.; Wang, Y.; Ye, C.; Feng, Y.; Wang, J.-P. Superparamagnetic Nanoparticle-
Based Viscosity Test. Appl. Phys. Lett. 2015, 107, 053701. 
(56)  Tu, L.; Wu, K.; Klein, T.; Wang, J.-P. Magnetic Nanoparticles Colourization by a Mixing-
Frequency Method. J. Phys. Appl. Phys. 2014, 47, 155001. 
(57)  Krishnan, K. M. Biomedical Nanomagnetics: A Spin through Possibilities in Imaging, 
Diagnostics, and Therapy. IEEE Trans. Magn. 2010, 46 (7), 2523–2558. 
(58)  Franklin, T. A. Ferrofluid Flow Phenomena, Massachusetts Institute of Technology, 2003. 
(59)  Green, M.; Pattrick, R.; Corr, S.; Imai, H.; Haigh, S.; Young, R.; Pradeep, T. Nanoscience: 
Volume 1: Nanostructures through Chemistry; Royal Society of Chemistry, 2012. 
(60)  Draack, S.; Viereck, T.; Kuhlmann, C.; Schilling, M.; Ludwig, F. Temperature-Dependent 
MPS Measurements. Int. J. Magn. Part. Imaging 2017, 3 (1). 
(61)  Perreard, I.; Reeves, D.; Zhang, X.; Kuehlert, E.; Forauer, E.; Weaver, J. Temperature of the 
Magnetic Nanoparticle Microenvironment: Estimation from Relaxation Times. Phys. Med. 
Biol. 2014, 59, 1109. 
(62)  Rauwerdink, A. M.; Hansen, E. W.; Weaver, J. B. Nanoparticle Temperature Estimation in 
Combined Ac and Dc Magnetic Fields. Phys. Med. Biol. 2009, 54, L51. 
 14 
(63)  Wu, K.; Ye, C.; Liu, J.; Wang, Y.; Feng, Y.; Wang, J.-P. In Vitro Viscosity Measurement on 
Superparamagnetic Nanoparticle Suspensions. IEEE Trans. Magn. 2016, 52 (7). 
(64)  Weaver, J. B.; Harding, M.; Rauwerdink, A. M.; Hansen, E. W. The Effect of Viscosity on 
the Phase of the Nanoparticle Magnetization Induced by a Harmonic Applied Field; 
International Society for Optics and Photonics, 2010; pp 762627-762627–762628. 
(65)  Wu, K.; Schliep, K.; Zhang, X.; Liu, J.; Ma, B.; Wang, J. Characterizing Physical Properties 
of Superparamagnetic Nanoparticles in Liquid Phase Using Brownian Relaxation. Small 
2017, 13, 1604135. 
(66)  Orlov, A. V.; Khodakova, J. A.; Nikitin, M. P.; Shepelyakovskaya, A. O.; Brovko, F. A.; 
Laman, A. G.; Grishin, E. V.; Nikitin, P. I. Magnetic Immunoassay for Detection of 
Staphylococcal Toxins in Complex Media. Anal. Chem. 2013, 85, 1154–1163. 
(67)  Orlov, A. V.; Bragina, V. A.; Nikitin, M. P.; Nikitin, P. I. Rapid Dry-Reagent 
Immunomagnetic Biosensing Platform Based on Volumetric Detection of Nanoparticles on 
3D Structures. Biosens. Bioelectron. 2016, 79, 423–429. 
(68)  Orlov, A. V.; Znoyko, S. L.; Cherkasov, V. R.; Nikitin, M. P.; Nikitin, P. I. Multiplex 
Biosensing Based on Highly Sensitive Magnetic Nanolabel Quantification: Rapid Detection 
of Botulinum Neurotoxins A, B, and E in Liquids. Anal. Chem. 2016, 88 (21), 10419–10426. 
(69)  Bragina, V. A.; Znoyko, S. L.; Orlov, A. V.; Pushkarev, A. V.; Nikitin, M. P.; Nikitin, P. I. 
Analytical Platform with Selectable Assay Parameters Based on Three Functions of Magnetic 
Nanoparticles: Demonstration of Highly Sensitive Rapid Quantitation of Staphylococcal 
Enterotoxin B in Food. Anal. Chem. 2019, 91 (15), 9852–9857. 
(70)  Guteneva, N. V.; Znoyko, S. L.; Orlov, A. V.; Nikitin, M. P.; Nikitin, P. I. Rapid Lateral 
Flow Assays Based on the Quantification of Magnetic Nanoparticle Labels for Multiplexed 
Immunodetection of Small Molecules: Application to the Determination of Drugs of Abuse. 
Microchim. Acta 2019, 186 (9), 621. 
(71)  Znoyko, S. L.; Orlov, A. V.; Pushkarev, A. V.; Mochalova, E. N.; Guteneva, N. V.; Lunin, 
A. V.; Nikitin, M. P.; Nikitin, P. I. Ultrasensitive Quantitative Detection of Small Molecules 
with Rapid Lateral-Flow Assay Based on High-Affinity Bifunctional Ligand and Magnetic 
Nanolabels. Anal. Chim. Acta 2018, 1034, 161–167. 
 15 
(72)  Nikitin, M.; Orlov, A.; Znoyko, S.; Bragina, V.; Gorshkov, B.; Ksenevich, T.; Cherkasov, V.; 
Nikitin, P. Multiplex Biosensing with Highly Sensitive Magnetic Nanoparticle 
Quantification Method. J. Magn. Magn. Mater. 2018, 459, 260–264. 
 
